Previous 10 | Next 10 |
2023-11-05 07:58:25 ET Summary IDEXX Laboratories specializes in diagnostic products and services for veterinary and water testing markets, which usually present a high recurrence. The pet healthcare market expects solid growth in the coming years and has qualities that make it re...
2023-11-05 03:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-04 12:45:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Focused Growth Fund declined 5.29% in Q3 but outperformed the benchmark by 155 b...
2023-11-02 12:27:23 ET Summary IDEXX Laboratories operates in the veterinarian health sector and has experienced double-digit revenue growth in recent years. The company is facing short-term headwinds due to lower vet visits caused by economic challenges. IDEXX is focused on c...
2023-11-01 13:04:45 ET Shares of IDEXX Laboratories ( NASDAQ: IDXX ) on Wednesday fell as much as 6.8% , after the pet healthcare company saw a quarterly same-store decline in its U.S. clinical business and revised its full year revenue guidance. IDXX stock was last down 3...
2023-11-01 11:39:08 ET IDEXX Laboratories, Inc. (IDXX) Q3 2023 Earnings Conference Call November 1, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Chief Financial Officer John Ravis - Vice President, Inves...
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
2023-11-01 06:36:29 ET More on IDEXX Laboratories IDEXX Laboratories: Long-Term Growth Remains Attractive IDEXX Laboratories Q3 2023 Earnings Preview First U.S. bird flu case detected from commercial farm since April Seeking Alpha’s Quant Rating on IDE...
IDEXX Laboratories Inc. (IDXX) is expected to report $2.37 for Q3 2023
2023-10-31 13:38:30 ET More on IDEXX Laboratories IDEXX Laboratories: Long-Term Growth Remains Attractive First U.S. bird flu case detected from commercial farm since April Seeking Alpha’s Quant Rating on IDEXX Laboratories Historical earnings data for...
News, Short Squeeze, Breakout and More Instantly...
IDEXX Laboratories Inc. Company Name:
IDXX Stock Symbol:
NASDAQ Market:
IDEXX Laboratories Inc. Website:
2024-06-28 23:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day. ...
2024-06-24 08:00:11 ET Jonathan Block from Stifel Nicolaus issued a price target of $510.00 for IDXX on 2024-06-24 07:19:00. The adjusted price target was set to $510.00. At the time of the announcement, IDXX was trading at $495.73. The overall price target consensus is ...